Advanced search
Publication Cover
Expert Opinion on Drug Discovery Volume 5, 2010 - Issue 2
Submit an article Journal homepage
152
Views
5
CrossRef citations to date
0
Altmetric
Reviews

Non-mammalian animal models of Parkinson's disease for drug discovery

Kah-Leong Lim National Neuroscience Institute, Neurodegeneration Research Laboratory, 11 Jalan Tan Tock Seng, 308433, Singapore + 65 6357 7520; +65 6256 9178; [email protected]; Duke-NUS Graduate Medical School, Singapore; National University of Singapore, Department of Physiology, Singapore
, PhD
Pages 165-176 | Published online: 05 Jan 2010

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ranjana Himalian, Sandeep Kumar Singh & Mahendra Pratap Singh. (2022) Ameliorative Role of Nutraceuticals on Neurodegenerative Diseases Using the Drosophila melanogaster as a Discovery Model to Define Bioefficacy. Journal of the American Nutrition Association 41:5, pages 511-539.
Read now

Articles from other publishers (4)

Liang Ma, Xi Li, Chengyu Liu, Wanyao Yan, Jinlu Ma, Robert B. Petersen, Anlin Peng & Kun Huang. (2022) Modelling Parkinson's Disease in C. elegans : Strengths and Limitations . Current Pharmaceutical Design 28:37, pages 3033-3048.
Crossref
Savannah M. Rocha, Collin M. Bantle, Tawfik Aboellail, Debotri Chatterjee, Richard J. Smeyne & Ronald B. Tjalkens. (2022) Rotenone induces regionally distinct α-synuclein protein aggregation and activation of glia prior to loss of dopaminergic neurons in C57Bl/6 mice. Neurobiology of Disease 167, pages 105685.
Crossref
Joana LamaYazead BuhidmaEdward J.R. FletcherSusan Duty. (2021) Animal models of Parkinson’s disease: a guide to selecting the optimal model for your research. Neuronal Signaling 5:4.
Crossref
Joost Schulte, Katharine J. Sepp, Chaohong Wu, Pengyu Hong & J. Troy Littleton. (2011) High-Content Chemical and RNAi Screens for Suppressors of Neurotoxicity in a Huntington's Disease Model. PLoS ONE 6:8, pages e23841.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.